Finance

Lists
NYMXF:OTCMKTS
Nymox Pharmaceutical Corp
USD 0,032
0,00%
(0,00) 1D
15 Okt., 13:44:39 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NYMXF...
Open
USD 0,03
High
USD 0,03
Low
USD 0,03
Mkt. cap
3,59 m
Avg. vol.
8,16 k
Volume
2,45 k
52-wk high
USD 0,20
52-wk low
USD 0,00
EPS
-USD 0,04
Beta
-0,15
Shares outstanding
105,04 m
No. of employees
3
Open
USD 0,03
High
USD 0,03
Low
USD 0,03
Mkt. cap
3,59 m
Avg. vol.
8,16 k
Volume
2,45 k
52-wk high
USD 0,20
52-wk low
USD 0,00
EPS
-USD 0,04
Beta
-0,15
Shares outstanding
105,04 m
No. of employees
3
News stories
From web sources and news partners
About Nymox Pharmaceutical Corp
CEO-
Employees3
Founded1989
Headquarters-
Sector-
Websitenymox.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2015
Des. 2015
Sep. 2024
Des. 2024
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
511,00 k
624,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
142,00 k
164,00 k
Operating expense
-
-
653,00 k
788,00 k
Total operating expenses
-
-
653,00 k
788,00 k
Operating income
-
-
-653,00 k
-788,00 k
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-716,00 k
-857,00 k
EBT excluding unusual items
-
-
-716,00 k
-857,00 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-716,00 k
-857,00 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
2,00 k
Interest expense
-
-
-63,00 k
-86,00 k
Net interest expenses
-
-
-63,00 k
-84,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-652,67 k
-788,00 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme